Zheng Xing Xing Ye Ri Bao·2025-09-18 08:52Market Overview - On September 18, the biopharmaceutical sector declined by 0.38%, with Kanghua Biotech leading the drop [1] - The Shanghai Composite Index closed at 3831.66, down 1.15%, while the Shenzhen Component Index closed at 13075.66, down 1.06% [1] Stock Performance - Notable gainers in the biopharmaceutical sector included: - Changchun High-tech: Closed at 130.31, up 5.19% with a trading volume of 233,800 shares and a turnover of 3.024 billion [1] - Zhifei Biological Products: Closed at 22.66, up 4.04% with a trading volume of 925,800 shares and a turnover of 2.12 billion [1] - ST Weiming: Closed at 8.88, up 3.26% with a trading volume of 182,300 shares and a turnover of 162 million [1] - Conversely, Kanghua Biotech experienced a significant decline, closing at 75.88, down 3.46% with a trading volume of 49,100 shares and a turnover of 381 million [2] Capital Flow - The biopharmaceutical sector saw a net inflow of 221 million from institutional investors, while retail investors experienced a net outflow of 340 million [2] - Key stocks with notable capital flows included: - Changchun High-tech: Net inflow of 353 million from institutional investors, with a net outflow of 283 million from retail investors [3] - Zhifei Biological Products: Net inflow of 10 million from institutional investors, with a net outflow of 125 million from retail investors [3] - Anke Bio: Net inflow of 64 million from institutional investors, with a net outflow of 877 million from retail investors [3]